AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Issue

Thursday, March 19, 2020


In The News


A brain scan-blood panel method accurately estimated brain degeneration in human participants and in animal subjects exposed to repetitive, low-level blasts, showing promise for earlier detection of brain damage in war veterans. The study, published in Molecular Psychiatry, also suggested that neurofilament light chain (Nf-L) measurements could become a key…
Could robots one day replace phlebotomists in performing routine venipuncture? Researchers at Rutgers University–New Brunswick demonstrated the efficacy and safety of using a hand-held robotic device to draw blood in a small cohort of patients, setting the stage for this possibility. “A device like ours could help clinicians get blood…
A study in the European Heart Journal suggests that glucagon-like peptide 1 levels (GLP-1) could help stratify risk of acute myocardial infarction (MI), guiding more personalized treatment and better clinical outcomes. Squaring off against more established cardiac markers such as troponin and N-terminal pro-B-type natriuretic peptide (NT-proBNP), GLP-1 emerged as…

AACC Alert


Laboratorians under age 40 and trainees in search of career building and camaraderie have a prime resource in AACC’s Society for Young Clinical Laboratorians (SYCL), which presents a range of networking, mentorship, programming, and recognition opportunities.

Practice Management


Aiming for a checks and balances system on pharmacogenetic tests, two U.S. Food and Drug Administration (FDA) centers have collaborated on a website that lists genetic variants known to affect drug therapies, and they’ve invited public comment about pharmacogenomic associations that should or shouldn’t be on the list. Through this…

World View